Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer

Quenel-Tueux, N, Debled, M, Rudewicz, J et al. (18 more authors) (2015) Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer. British Journal of Cancer, 113 (4). pp. 585-594. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Quenel-Tueux, N
  • Debled, M
  • Rudewicz, J
  • MacGrogan, G
  • Pulido, M
  • Mauriac, L
  • Dalenc, F
  • Bachelot, T
  • Lortal, B
  • Breton-Callu, C
  • Madranges, N
  • Tunon de Lara, C
  • Fournier, M
  • Bonnefoi, H
  • Soueidan, H
  • Nikolski, M
  • Gros, A
  • Daly, C
  • Wood, H
  • Rabbitts, P
  • Iggo, R
Copyright, Publisher and Additional Information: (c) 2015 Cancer Research UK. All rights reserved. This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License.
Keywords: anastrozole; endocrine treatment; fulvestrant; hormone-receptor-positive cancer; large operable or locally-advanced breast cancer; neo-adjuvant
Dates:
  • Published: 11 August 2015
  • Accepted: 15 June 2015
Institution: The University of Leeds
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchUNKNOWN
Depositing User: Symplectic Publications
Date Deposited: 17 Jul 2015 13:34
Last Modified: 25 Feb 2016 13:11
Published Version: http://dx.doi.org/10.1038/bjc.2015.247
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.2015.247

Share / Export

Statistics